Last reviewed · How we verify
QuadraMune(TM) for Prevention of COVID-19
QuadraMune(TM) is a nutritional supplement which has previously been demonstrated to possess antiinflammatory and immune modulatory activity based on in vitro and pilot in vivo studies. The current clinical trial aims to assess in a 500 volunteer trial the efficacy of QuadraMune(TM) in reducing infection in individuals at high risk of COVID-19.
Details
| Lead sponsor | Therapeutic Solutions International |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 500 |
| Start date | Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Nov 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Covid19
- Coronavirus
- SARS-CoV 2
Interventions
- QuadraMune(TM)
Countries
United States